Nektar to Announce Financial Results for the Second Quarter 2020 on Thursday, August 6, 2020, After Close of U.S.-Based Financial Markets

Rhea-AI Summary

Nektar Therapeutics (Nasdaq: NKTR) will announce its second quarter 2020 financial results on August 6, 2020, post-market. CEO Howard Robin will lead a conference call at 5:00 PM ET to discuss the results. Interested parties can access the press release and a live audio-only webcast on Nektar's website. The replay of the call will be available until September 1, 2020. Nektar Therapeutics specializes in biopharmaceuticals, focusing on oncology and immunology.

Positive

• Scheduled announcement of second quarter 2020 financial results, indicating ongoing financial communication with investors.

Negative

• None.

SAN FRANCISCO, July 28, 2020 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter 2020 on Thursday, August 6, 2020, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.

The press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the home page and Investors section of the Nektar website: http://ir.nektar.com/. The web broadcast of the conference call will be available for replay through Tuesday, September 1, 2020.

To access the conference call, follow these instructions:
     Dial: (877) 881-2183 (U.S.); (970) 315-0453 (international)
     Conference ID: 7858867 (Nektar Therapeutics is the host)

About Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology and immunology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Contacts:

For Investors:
Vivian Wu of Nektar Therapeutics
628-895-0661

View original content:http://www.prnewswire.com/news-releases/nektar-to-announce-financial-results-for-the-second-quarter-2020-on-thursday-august-6-2020-after-close-of-us-based-financial-markets-301101639.html

SOURCE Nektar Therapeutics

FAQ

When will Nektar Therapeutics announce its financial results for Q2 2020?

Nektar Therapeutics will announce its financial results for the second quarter of 2020 on August 6, 2020.

What time is the Nektar Therapeutics conference call regarding Q2 2020 results?

The conference call for Nektar Therapeutics' Q2 2020 results is scheduled for 5:00 PM ET on August 6, 2020.

How can I access the Nektar Therapeutics Q2 2020 financial results webcast?

The live audio-only webcast for Nektar Therapeutics' Q2 2020 financial results can be accessed through their Investors page on their website.

What type of company is Nektar Therapeutics?

Nektar Therapeutics is a biopharmaceutical company focused on oncology and immunology with a robust R&D pipeline.